State Ledger
Company profile

Pyxis Oncology, Inc. CIK 1782223

Ticker
PYXS (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA 02118
Fiscal year end
2025 (FY)
Market Data
Close
$2.01
Change
-$0.03
Change %
-1.47%
Volume
28,946

PYXS · trading date Oct 12, 2026 · previous close $2.04 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$13.86M
Net income
-$79.62M
Total assets
$91.52M
Total liabilities
$38.11M
Stockholders' equity
$53.41M
Cash & equivalents
$15.42M
Operating income
-$84.42M
Operating cash flow
-$63.50M
Capital expenditures
$9.0K

Fiscal year 2025, via 10-K filed 2026-03-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-609.2%
Net margin
-574.5%
Free cash flow
-$63.51M
Free cash flow margin
-458.3%
Liabilities / assets
41.6%
Equity / assets
58.4%
CapEx / revenue
0.1%
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $13.86M -$79.62M $91.52M $38.11M $53.41M
2024 $16.15M -$77.33M $157.18M $36.43M $120.75M
2023 — -$73.79M $173.73M $48.02M $125.70M
2022 — -$120.72M $211.38M $50.56M $160.82M
2021 — -$75.98M $280.02M $18.71M $261.31M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02118
321 HARRISON AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies